sulfur burps with tirzepatide burps” in patients on GLP-1 therapies may be more than a minor side effect. Experts note these symptoms can reflect underlying gastrointestinal changes linked to the drugs' mechanism of action. While GLP‑1 sulfur burps: why they

Thousands of lawsuits have been filed against the manufacturers for allegedly failing to warn about these risks, prioritizing profits over consumer safety

Tirzepatide is known as a twincretin or a combination of glucagon-like peptide 1 (GLP-1) receptor agonists and glucose-dependent insulinotropic polypetide (GIP) hormones

As part of a 2021 clinical trial published in JAMA , 741 people received weekly semaglutide injections, adjusted their diets and exercised for 20 weeks

A new signal: dysesthesia with retatrutide The TRIUMPH-4 Phase 3 trial revealed a side effect not previously highlighted in earlier data

Why Gallbladder Issues Are Discussed With GLP-1 Medications GLP-1 medications are associated with a higher risk of gallbladder issues

Conclusioni SURMOUNT-MAINTAIN ridefinisce il vocabolario del mantenimento del peso con i farmaci anti-obesit